NASDAQ:RDNT - RadNet Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$14.15 -0.15 (-1.05 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$14.30
Today's Range$14.15 - $14.30
52-Week Range$7.46 - $15.50
Volume99,700 shs
Average Volume270,386 shs
Market Capitalization$689.83 million
P/E Ratio49.14
Dividend YieldN/A
Beta0.4
RadNet logoRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the imaging industry, including picture archiving communications systems; and provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. As of December 31, 2017, it operated 297 facilities directly or indirectly through joint ventures with hospitals in California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Receive RDNT News and Ratings via Email

Sign-up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:RDNT
CUSIPN/A
Phone310-478-7808

Debt

Debt-to-Equity Ratio4.90
Current Ratio1.12
Quick Ratio1.12

Price-To-Earnings

Trailing P/E Ratio49.14
Forward P/E Ratio38.24
P/E Growth4.9

Sales & Book Value

Annual Sales$922.19 million
Price / Sales0.74
Cash Flow$1.7426 per share
Price / Cash8.12
Book Value$1.47 per share
Price / Book9.63

Profitability

EPS (Most Recent Fiscal Year)$0.29
Net Income$50,000.00
Net Margins-0.66%
Return on Equity18.77%
Return on Assets1.74%

Miscellaneous

Employees7,440
Outstanding Shares48,240,000
Market Cap$689.83

RadNet (NASDAQ:RDNT) Frequently Asked Questions

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

How were RadNet's earnings last quarter?

RadNet Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Wednesday, May, 9th. The medical research company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.19. The medical research company earned $231.39 million during the quarter, compared to analyst estimates of $234.32 million. RadNet had a negative net margin of 0.66% and a positive return on equity of 18.77%. The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.03) EPS. View RadNet's Earnings History.

When is RadNet's next earnings date?

RadNet is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for RadNet.

What price target have analysts set for RDNT?

3 equities research analysts have issued 12 month price objectives for RadNet's shares. Their predictions range from $14.00 to $15.00. On average, they anticipate RadNet's stock price to reach $14.6667 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price. View Analyst Ratings for RadNet.

What is the consensus analysts' recommendation for RadNet?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 buy rating and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Strong Buy."

Who are some of RadNet's key competitors?

Who are RadNet's key executives?

RadNet's management team includes the folowing people:
  • Dr. Howard G. Berger M.D., Chairman, Pres, CEO & Treasurer (Age 72)
  • Mr. Mark D. Stolper, Exec. VP & CFO (Age 47)
  • Mr. Jeffrey L. Linden, Exec. VP & Gen. Counsel (Age 75)
  • Mr. Norman R. Hames, Pres, COO of Western Operations & Director (Age 62)
  • Mr. Stephen M. Forthuber, Pres & COO of Eastern Operations (Age 57)

Has RadNet been receiving favorable news coverage?

Media coverage about RDNT stock has trended somewhat positive this week, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. RadNet earned a media sentiment score of 0.21 on Accern's scale. They also assigned press coverage about the medical research company an impact score of 45.98 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are RadNet's major shareholders?

RadNet's stock is owned by a number of of institutional and retail investors. Top institutional investors include Campbell & CO Investment Adviser LLC (0.02%). Company insiders that own RadNet stock include David L Swartz, Jeffrey L Linden, John V Crues, Lawrence L Levitt, Mark Stolper, Marvin S Cadwell, Michael L Md Sherman, Michael N Murdock, Norman R Hames, Sandy Nyholm Kaminsky and Stephen M Forthuber. View Institutional Ownership Trends for RadNet.

Which major investors are selling RadNet stock?

RDNT stock was sold by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC. Company insiders that have sold RadNet company stock in the last year include David L Swartz, Jeffrey L Linden, John V Crues, Lawrence L Levitt, Mark Stolper, Marvin S Cadwell, Michael L Md Sherman, Michael N Murdock, Norman R Hames, Sandy Nyholm Kaminsky and Stephen M Forthuber. View Insider Buying and Selling for RadNet.

How do I buy shares of RadNet?

Shares of RDNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $14.15.

How big of a company is RadNet?

RadNet has a market capitalization of $689.83 million and generates $922.19 million in revenue each year. The medical research company earns $50,000.00 in net income (profit) each year or $0.29 on an earnings per share basis. RadNet employs 7,440 workers across the globe.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVENUE, LOS ANGELES CA, 90025. The medical research company can be reached via phone at 310-478-7808 or via email at [email protected]


MarketBeat Community Rating for RadNet (NASDAQ RDNT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  215 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  394
MarketBeat's community ratings are surveys of what our community members think about RadNet and other stocks. Vote "Outperform" if you believe RDNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.